MedTrace Logo

Hypertonic Saline for Acute Bronchiolitis

NCT01247064 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2014-08-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether nebulized 3% hypertonic saline (HS) improves respiratory distress in children 2-23 months presenting to the emergency department (ED) with acute bronchiolitis with persistent respiratory distress after initial therapy with a trial of nebulized albuterol.

Conditions

  • Bronchiolitis, Viral
  • Saline Solution, Hypertonic

Interventions

DRUG

Nebulized 3% saline

4 mL of nebulized 3% saline once

DRUG

Nebulized 0.9% Normal Saline

4 mL of 0.9% nebulized normal saline once

Sponsors & Collaborators

Principal Investigators

  • Joseph Zorc, MD, MSCE · Children's Hospital of Philadelphia

  • Todd Florin, MD · Children's Hospital of Philadelphia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
23 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01247064 on ClinicalTrials.gov